Likewise, in another prospective observational cohort study including 79 IBD patients (32 CD and 47 UC patients), concomitant TNF antagonists were not associated with SARS-CoV-2-related pneumonia or death [79]. The gene discussed is TNF; the disease is inflammatory bowel disease.